Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Colorectal Neoplasms

  Free Subscription


13.11.2017

2 Am J Clin Oncol
1 Ann Surg Oncol
4 BMC Cancer
4 Br J Cancer
1 Cancer
6 Dis Colon Rectum
1 Eur J Gastroenterol Hepatol
2 Gastroenterology
1 Gastrointest Endosc
1 Gut
1 Hum Pathol
1 Int J Cancer
2 Int J Colorectal Dis
2 Int J Oncol
2 J Natl Cancer Inst
1 J Surg Oncol
2 Oncol Rep
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Clin Oncol

  1. YEOP OH S, Bae Kim Y, Wook Suh K
    Oncologic Outcome of ypT1-2N0 Rectal Cancer After Neoadjuvant Chemoradiotherapy Compared With pT1-2N0 Rectal Cancer.
    Am J Clin Oncol. 2017;40:512-516.
    PubMed     Text format     Abstract available

  2. CHARLTON ME, Karlitz JJ, Schlichting JA, Chen VW, et al
    Factors Associated With Guideline-recommended KRAS Testing in Colorectal Cancer Patients: A Population-based Study.
    Am J Clin Oncol. 2017;40:498-506.
    PubMed     Text format     Abstract available


    Ann Surg Oncol

  3. DURAES LC, Stocchi L, Steele SR, Kalady MF, et al
    The Relationship Between Clavien-Dindo Morbidity Classification and Oncologic Outcomes After Colorectal Cancer Resection.
    Ann Surg Oncol. 2017 Nov 7. doi: 10.1245/s10434-017-6142.
    PubMed     Text format     Abstract available


    BMC Cancer

  4. TAKAHASHI H, Takahashi M, Ohnuma S, Unno M, et al
    microRNA-193a-3p is specifically down-regulated and acts as a tumor suppressor in BRAF-mutated colorectal cancer.
    BMC Cancer. 2017;17:723.
    PubMed     Text format     Abstract available

  5. YANG C, Zou K, Zheng L, Xiong B, et al
    Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review.
    BMC Cancer. 2017;17:725.
    PubMed     Text format     Abstract available

  6. YU X, Mi L, Dong J, Zou J, et al
    Long intergenic non-protein-coding RNA 1567 (LINC01567) acts as a "sponge" against microRNA-93 in regulating the proliferation and tumorigenesis of human colon cancer stem cells.
    BMC Cancer. 2017;17:716.
    PubMed     Text format     Abstract available

  7. ALONSO-MOLERO J, Gonzalez-Donquiles C, Fernandez-Villa T, de Souza-Teixeira F, et al
    Alterations in PGC1alpha expression levels are involved in colorectal cancer risk: a qualitative systematic review.
    BMC Cancer. 2017;17:731.
    PubMed     Text format     Abstract available


    Br J Cancer

  8. GOEL A
    IGF-1R: SUMO-ing its weight in chemoresistant colorectal cancer.
    Br J Cancer. 2017 Nov 9. doi: 10.1038/bjc.2017.
    PubMed     Text format    

  9. CODONY-SERVAT J, Cuatrecasas M, Asensio E, Montironi C, et al
    Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancer.
    Br J Cancer. 2017 Nov 9. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available

  10. GOLLINS S, West N, Sebag-Montefiore D, Myint AS, et al
    Preoperative chemoradiation with capecitabine, irinotecan and cetuximab in rectal cancer: significance of pre-treatment and post-resection RAS mutations.
    Br J Cancer. 2017;117:1286-1294.
    PubMed     Text format     Abstract available

  11. GOEY KKH, Elias SG, Hinke A, van Oijen MGH, et al
    Clinicopathological factors influencing outcome in metastatic colorectal cancer patients treated with fluoropyrimidine and bevacizumab maintenance treatment vs observation: an individual patient data meta-analysis of two phase 3 trials.
    Br J Cancer. 2017 Nov 9. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    Cancer

  12. ZHANG J, Raju GS, Chang DW, Lin SH, et al
    Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
    Cancer. 2017 Nov 7. doi: 10.1002/cncr.31062.
    PubMed     Text format     Abstract available


    Dis Colon Rectum

  13. TIERNEY J, Vitale GC
    Spigelman Scoring System Underestimates the Risk of Ampullary and Duodenal Carcinoma in Patients With Familial Adenomatous Polyposis With Duodenal Polyposis.
    Dis Colon Rectum. 2017;60:1119-1120.
    PubMed     Text format    

  14. MAYKEL JA
    Comprehensive Training and Safe Implementation of a Transanal Total Mesorectal Excision Program.
    Dis Colon Rectum. 2017;60:995-996.
    PubMed     Text format    

  15. SAFIRI S, Ayubi E
    Early Postoperative Decrease of Serum Albumin Predicts Surgical Outcome in Patients Undergoing Colorectal Resection: Methodologic Issues.
    Dis Colon Rectum. 2017;60:1114.
    PubMed     Text format    

  16. CLARK SK, Latchford A
    Surveillance of Duodenal Polyposis in Familial Adenomatous Polyposis: Should the Spigelman Score Be Modified?
    Dis Colon Rectum. 2017;60:1117-1118.
    PubMed     Text format    

  17. WANIS KN, Patel SVB, Brackstone M
    Do Moderate Surgical Treatment Delays Influence Survival in Colon Cancer?
    Dis Colon Rectum. 2017;60:1241-1249.
    PubMed     Text format     Abstract available

  18. GALIZIA G, Lieto E, Auricchio A, Cardella F, et al
    Naples Prognostic Score, Based on Nutritional and Inflammatory Status, is an Independent Predictor of Long-term Outcome in Patients Undergoing Surgery for Colorectal Cancer.
    Dis Colon Rectum. 2017;60:1273-1284.
    PubMed     Text format     Abstract available


    Eur J Gastroenterol Hepatol

  19. LEE JW, Baek MJ, Ahn TS, Lee SM, et al
    Fluorine-18-fluorodeoxyglucose uptake of bone marrow on PET/CT can predict prognosis in patients with colorectal cancer after curative surgical resection.
    Eur J Gastroenterol Hepatol. 2017 Nov 8. doi: 10.1097/MEG.0000000000001018.
    PubMed     Text format     Abstract available


    Gastroenterology

  20. GINI A, Zauber AG, Cenin DR, Omidvari AH, et al
    Cost Effectiveness of Screening Individuals with Cystic Fibrosis for Colorectal Cancer.
    Gastroenterology. 2017 Nov 1. pii: S0016-5085(17)36296.
    PubMed     Text format     Abstract available

  21. JOBIN C
    Human Intestinal Microbiota and Colorectal Cancer: Moving Beyond Associative Studies.
    Gastroenterology. 2017 Oct 31. pii: S0016-5085(17)36290.
    PubMed     Text format    


    Gastrointest Endosc

  22. POLYDORIDES AD, Harpaz N
    Serrated lesions in inflammatory bowel disease.
    Gastrointest Endosc. 2017;85:461.
    PubMed     Text format    


    Gut

  23. WAN L, Yu W, Shen E, Sun W, et al
    SRSF6-regulated alternative splicing that promotes tumour progression offers a therapy target for colorectal cancer.
    Gut. 2017 Nov 7. pii: gutjnl-2017-314983. doi: 10.1136/gutjnl-2017-314983.
    PubMed     Text format     Abstract available


    Hum Pathol

  24. MAMOORI A, Wahab R, Islam F, Lee K, et al
    Clinical and biological significance of miR-193a-3p targeted KRAS in colorectal cancer pathogenesis.
    Hum Pathol. 2017 Nov 2. pii: S0046-8177(17)30393.
    PubMed     Text format     Abstract available


    Int J Cancer

  25. DI J, Yang H, Jiang B, Wang Z, et al
    Whole exome sequencing reveals intertumor heterogeneity and distinct genetic origins of sporadic synchronous colorectal cancer.
    Int J Cancer. 2017 Nov 6. doi: 10.1002/ijc.31140.
    PubMed     Text format     Abstract available


    Int J Colorectal Dis

  26. VAN WAART H, Stuiver MM, van Harten WH, Geleijn E, et al
    Recruitment to and pilot results of the PACES randomized trial of physical exercise during adjuvant chemotherapy for colon cancer.
    Int J Colorectal Dis. 2017 Nov 9. doi: 10.1007/s00384-017-2921.
    PubMed     Text format     Abstract available

  27. MALMSTROM ML, Brisling S, Klausen TW, Saftoiu A, et al
    Staging with computed tomography of patients with colon cancer.
    Int J Colorectal Dis. 2017 Nov 7. doi: 10.1007/s00384-017-2932.
    PubMed     Text format     Abstract available


    Int J Oncol

  28. IZDEBSKA M, Gagat M, Grzanka A
    Overexpression of lamin B1 induces mitotic catastrophe in colon cancer LoVo cells and is associated with worse clinical outcomes.
    Int J Oncol. 2017 Nov 1. doi: 10.3892/ijo.2017.4182.
    PubMed     Text format     Abstract available

  29. TANG YC, Zhang Y, Zhou J, Zhi Q, et al
    Ginsenoside Rg3 targets cancer stem cells and tumor angiogenesis to inhibit colorectal cancer progression in vivo.
    Int J Oncol. 2017 Nov 1. doi: 10.3892/ijo.2017.4183.
    PubMed     Text format     Abstract available


    J Natl Cancer Inst

  30. MURPHY CC, Sanoff HK, Stitzenberg KB, Baron JA, et al
    RE: Colorectal Cancer Incidence Patterns in the United States, 1974-2013.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format    

  31. MOLENAAR RJ, Radivoyevitch T, Wilmink JW
    RE: Colorectal Cancer Incidence Patterns in the United States, 1974-2013.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format    


    J Surg Oncol

  32. CHOE EK, Park KJ, Ryoo SB, Moon SH, et al
    The impact of visceral adipose tissue amount on the adequacy of lymph node retrieval in colorectal cancer surgery.
    J Surg Oncol. 2017 Nov 9. doi: 10.1002/jso.24876.
    PubMed     Text format     Abstract available


    Oncol Rep

  33. LI J, Li X, Cen C, Ai X, et al
    The long non-coding RNA ENST00000547547 reduces 5-fluorouracil resistance of colorectal cancer cells via competitive binding to microRNA-31.
    Oncol Rep. 2017 Nov 7. doi: 10.3892/or.2017.6082.
    PubMed     Text format     Abstract available

  34. WANG D, Rai B, Qi F, Liu T, et al
    Influence of the Twist gene on the invasion and metastasis of colon cancer.
    Oncol Rep. 2017 Nov 6. doi: 10.3892/or.2017.6076.
    PubMed     Text format     Abstract available


    PLoS One

  35. BRAND EC, Crook JE, Thomas CS, Siersema PD, et al
    Development and validation of a prediction model for adenoma detection during screening and surveillance colonoscopy with comparison to actual adenoma detection rates.
    PLoS One. 2017;12:e0185560.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: